Signal2026-07-09
ClinicalTrials.gov

[PHASE2] Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: Comparing One Versus Two Doses of Psilocybin

Part of

Advancing Psychedelic And Novel Therapeutics